Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Metformin helps induce ovulation in obese women with PCOS, but weight loss is still the main treatment.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Most patients improved with oral contraceptives, but some needed additional treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Skin tags in obese individuals may indicate a higher risk of heart disease and diabetes.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Insulin resistance plays a key role in PCOS, and lifestyle changes, weight loss, and medications like metformin can help manage it.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.